{"disease":{"id":"liver-cirrhosis-biliary","name":"liver cirrhosis biliary"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05740358","title":"Liver Cirrhosis Network Cohort Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1222,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT02308111","title":"Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":334,"lead_sponsor_name":"Intercept Pharmaceuticals","has_results":true},{"nct_id":"NCT00570765","title":"Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Intercept Pharmaceuticals","has_results":true},{"nct_id":"NCT04629456","title":"Physical Therapy for Liver Cirrhosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT03630718","title":"Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT00125281","title":"SAMe to Treat Biliary Cirrhosis Symptoms","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":50,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03265249","title":"BRIDGE Device for Post-operative Pain Control","phase":"NA","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"Duke University","has_results":true},{"nct_id":"NCT03633227","title":"Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":22,"lead_sponsor_name":"Intercept Pharmaceuticals","has_results":true},{"nct_id":"NCT03468699","title":"Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Vinmec Research Institute of Stem Cell and Gene Technology","has_results":false},{"nct_id":"NCT03476993","title":"Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Biocad","has_results":false},{"nct_id":"NCT04047160","title":"Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Kiminori Kimura, MD","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}